$40 Million
Lead Placement Agent
PIPE
April 2024
$500 Million
Joint Bookrunning Manager
Follow-On
April 2024
$280 Million
Lead Placement Agent
PIPE
April 2024
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of Tenet Medicines
Pending
€15 Million
Lead Placement Agent
Private Placement
April 2024
$275 Million
Placement Agent
Private Placement
April 2024
UNDISCLOSED
Lead Financial Advisor
Sale to XOMA Corporation
April 2024
$185 Million
Investment Banker
Asset Purchase Agreement with Merz Therapeutics
April 2024
$100 Million
Joint Bookrunner
Initial Public Offering
March 2024
$240 Million
Joint Bookrunner
Follow-On
March 2024
UNDISCLOSED
Exclusive Financial Advisor and Placement Agent
Merger with Homology Medicines & Concurrent $42M Private Placement
March 2024
UNDISCLOSED
Exclusive Financial Advisor
Merger with LENZ Therapeutics
March 2024